Published: April 2017
Read Executive Summary
Read Full-Text Guideline
This collaborative guideline focuses on the following four topics: 1) shared decision making between physicians and patients with localized prostate cancer; 2) care options based on cancer severity/risk group, from very low risk to high risk; 3) it evaluates a variety of treatment options in this setting, including active surveillance, prostatectomy, radiation therapy, cryosurgery and high-intensity focused ultrasound and focal therapy; and 4) discusses side effects, health-related quality of life, and follow-up for patients treated for localized prostate tumors.
Developed in collaboration with:
Challenging Cases in the Management of Newly Diagnosed and Recurrent Prostate Cancer (CME)